Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

View source ↗

Summary

A ClinicalTrials.gov study is recruiting to observe how Avacincaptad Pegol (Izervay) is used in clinical practice for geographic atrophy and age-related macular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IZERVAY (avacincaptad pegol)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Geographic Atrophy, Macular Degeneration | Status: RECRUITING